X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/26/2870437/0/en/Cidara-Therapeutics-Announces-Presentations-Highlighting-Phase-1-and-Phase-2a-Clinical-Data-on-CD388-at-ESCMID-2024.html
https://www.fiercebiotech.com/biotech/cidara-regains-rights-flu-med-after-janssen-makes-good-promise-divest
https://www.globenewswire.com/news-release/2024/04/24/2869086/0/en/Cidara-Therapeutics-Reacquires-Global-Development-and-Commercial-Rights-to-CD388-and-Announces-Private-Placement-Financing-of-240-Million.html
https://www.globenewswire.com/news-release/2024/04/24/2869049/0/en/Cidara-Therapeutics-Announces-Divestiture-of-Rezafungin-to-Mundipharma-to-Focus-on-Advancing-the-Clinical-Development-of-Cloudbreak-DFC-Pipeline.html
https://www.globenewswire.com/news-release/2024/04/22/2867269/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/22/2867265/0/en/Cidara-Therapeutics-Announces-Receipt-of-Nasdaq-Delinquency-Notice.html
https://www.globenewswire.com/news-release/2024/04/22/2866891/0/en/Cidara-Therapeutics-Announces-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2024/04/05/2858706/0/en/Cidara-Therapeutics-Presents-Promising-New-Data-on-Novel-Drug-Fc-Conjugate-Candidates-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2024/03/06/2841387/0/en/Cidara-Therapeutics-to-Present-Preclincal-Data-on-Multiple-Novel-Drug-Fc-Conjugate-Candidates-at-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2024/02/12/2827490/0/en/Cidara-Therapeutics-Receives-11-14-Million-Milestone-Payment-Following-European-Approval-of-REZZAYO.html
Market Place
Share 
